Hmgb1/2 inhibits genotoxic stress in polyglutamine diseases by interacting with mutant ataxin-1 and huntingtin protein (Qi et al., 2007); suppressing Hmgb2 expression causes gastric cancer cells to be less sensitive to chemotherapy (An et al., 2015). This evidence concerns the gene HMGB2 and gastric cancer.